How to identify and validate drug toxicology
Would knowing the essential toxicity test and the best predictive tools benefit your drug discovery activities?
Dr Frank Bonner, CEO of Stem Cells for Safer Medicines addressed just this by looking at drug screening and toxicity profiling at the 7th Annual World Stem Cells and Regenerative Medicine Congress 2012 which took place in London in May this year.
Frank went on to discuss the impact more predictive testing platforms could have on drug discovery, and how well stem cell-based models model real life metabolic activity. He also talked about the current and future plans for the SC4SM Predictive Toxicology Consortium.
DOWNLOAD the presentation slides now to find out the details!
Do you want to find out more?